Corrigendum: Isorhamnetin Inhibits Human Gallbladder Cancer Cell Proliferation and Metastasis via PI3K/AKT Signaling Pathway Inactivation

Frontiers in Pharmacology

Longyang Jin¹  Xiaofeng Yu²  Chao Han³  Xiaoyu Zhang⁴  Zhenyu Hei⁴  Audrey Tsznam Ko⁵  Tianyu Zhai⁶  Jiandong Wang⁶ 

[1] Department of Colorectal Surgery, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, China;Department of General Surgery, People’s Hospital of Gaoxin District, Suzhou, China;Department of General Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China;Department of General Surgery, Xinhua Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China;Faculty of Medicine, Imperial College London, London, United Kingdom;Shanghai Key Laboratory of Biliary Tract Disease Research, Shanghai, China;Shanghai Research Center of Biliary Tract Disease, Shanghai, China;

关键词: isorhamnetin;    gallbladder cancer;    tumor progression;    PI3K/Akt pathway;    apoptosis;   

DOI  :  10.3389/fphar.2021.792330

来源: DOAJ

【 授权许可】

Unknown